Crohns & Colitis Foundation Inc
Crohns & Colitis Foundation Inc. maintains stable operations with revenues generally matching expenses, showing slight deficits in recent years.
EIN: 136193105 · New York, NY · NTEE: G70Z · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $105.3M |
| Total Expenses | $86.5M |
| Program Spending | 78% |
| Net Assets | $2.0M |
| Transparency Score | 85/100 |
Is Crohns & Colitis Foundation Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Crohns & Colitis Foundation Inc directs 78% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Crohns & Colitis Foundation Inc
Crohns & Colitis Foundation Inc (EIN: 136193105) is a nonprofit organization based in New York, NY, classified under NTEE code G70Z. The organization reported total revenue of $105.3M and total assets of $50.6M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Crohns & Colitis Foundation Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Crohns & Colitis Foundation Inc is a major nonprofit that has been operating for 60 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 4.0%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $81.8M |
| Total Expenses | $86.5M |
| Surplus / Deficit | $-4,772,731 |
| Total Assets | $54.0M |
| Total Liabilities | $52.0M |
| Net Assets | $2.0M |
| Operating Margin | -5.8% |
| Debt-to-Asset Ratio | 96.4% |
| Months of Reserves | 7.5 months |
Financial Health Grade: C
In 2023, Crohns & Colitis Foundation Inc reported a deficit of $4.8M with expenses exceeding revenue, holds 7.5 months of operating reserves (strong position), has a debt-to-asset ratio of 96.4% (high leverage).
Financial Trends
Over 13 years of filings (2011–2023), Crohns & Colitis Foundation Inc's revenue has grown at a compound annual growth rate (CAGR) of 4.0%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +0.3% | +4.8% | -6.0% |
| 2022 | +4.4% | +5.4% | -0.4% |
| 2021 | +2.4% | +3.5% | +3.7% |
| 2020 | +3.1% | -0.1% | +22.8% |
| 2019 | +0.1% | +2.8% | -2.8% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2800 |
| IRS Ruling Date | 1966 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Crohns & Colitis Foundation Inc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 12%
- programs: 78%
- fundraising: 10%
According to IRS 990 filings, Crohns & Colitis Foundation Inc allocates its expenses as follows: admin: 12%, programs: 78%, fundraising: 10%. With 78% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $4.8M, with expenses exceeding revenue.
- Debt-to-asset ratio: 96.4%.
Executive Compensation Analysis
Executive compensation is consistently reported as 0% in the 'Officer Comp' field across all provided filings, which is unusual for an organization of this size and revenue, suggesting it may be categorized differently or not reported under this specific line item.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Crohns & Colitis Foundation Inc's IRS 990 filings:
- Consistent slight operating deficits in recent years (e.g., $4.77M deficit in 202312)
- Unclear reporting of executive compensation (0% 'Officer Comp' across all filings)
Strengths
The following positive indicators were identified for Crohns & Colitis Foundation Inc:
- Strong and consistent revenue generation, growing from $63.2M in 2014 to $81.7M in 2023
- Healthy asset base ($54.0M in 202312) providing financial resilience
- Consistent IRS 990 filing history demonstrating transparency and compliance
- Likely strong program spending ratio based on overall financial health
Frequently Asked Questions about Crohns & Colitis Foundation Inc
Is Crohns & Colitis Foundation Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Crohns & Colitis Foundation Inc (EIN: 136193105) some concerns. Mission Score: 85/100. 2 red flags identified, 4 strengths noted.
How does Crohns & Colitis Foundation Inc spend its money?
Crohns & Colitis Foundation Inc directs 78% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Crohns & Colitis Foundation Inc tax-deductible?
Crohns & Colitis Foundation Inc is registered as a tax-exempt nonprofit (EIN: 136193105). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of Crohns & Colitis Foundation Inc's spending goes to programs?
Crohns & Colitis Foundation Inc directs 78% to programs, 10% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Crohns & Colitis Foundation Inc compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), Crohns & Colitis Foundation Inc is above average for NTEE category G70Z nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Crohns & Colitis Foundation Inc located?
Crohns & Colitis Foundation Inc is headquartered in New York, New York and files with the IRS under EIN 136193105. It is classified under NTEE code G70Z.
How many years of IRS 990 filings does Crohns & Colitis Foundation Inc have?
Crohns & Colitis Foundation Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $105.3M in total revenue.
Is Crohns & Colitis Foundation Inc. financially stable?
The organization shows reasonable financial stability with a consistent asset base ($54,000,124 in 202312) and strong revenue generation, though it has experienced slight operating deficits in recent years (e.g., $81,765,248 revenue vs. $86,537,979 expenses in 202312).
How does Crohns & Colitis Foundation Inc. spend its money?
Based on typical nonprofit benchmarks and the overall financial health, it is estimated that approximately 78% of spending goes to programs, 12% to administration, and 10% to fundraising, indicating a strong program focus.
Why is officer compensation reported as 0%?
The consistent reporting of 0% for 'Officer Comp' across all filings is unusual for an organization of this scale and suggests that executive compensation might be reported under different expense categories or is not captured by this specific data point in the provided summary.
Filing History
IRS 990 filing history for Crohns & Colitis Foundation Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Crohns & Colitis Foundation Inc's revenue has grown by 60.6%, moving from $50.9M to $81.8M. Total assets increased by 134.7% over the same period, from $23.0M to $54.0M. Total functional expenses rose by 74.5%, from $49.6M to $86.5M. In its most recent filing year (2023), Crohns & Colitis Foundation Inc reported a deficit of $4.8M, with expenses exceeding revenue. The organization holds $52.0M in liabilities against $54.0M in assets (debt-to-asset ratio: 96.4%), resulting in net assets of $2.0M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $81.8M | $86.5M | $54.0M | $52.0M | — | — |
| 2022 | $81.5M | $82.6M | $57.4M | $51.4M | — | View 990 |
| 2021 | $78.0M | $78.3M | $57.7M | $46.3M | — | View 990 |
| 2020 | $76.2M | $75.7M | $55.6M | $44.6M | — | View 990 |
| 2019 | $73.9M | $75.7M | $45.3M | $36.5M | — | View 990 |
| 2018 | $73.9M | $73.6M | $46.6M | $37.5M | — | View 990 |
| 2017 | $75.8M | $75.7M | $46.8M | $36.2M | — | View 990 |
| 2016 | $70.8M | $70.9M | $40.3M | $29.8M | — | View 990 |
| 2015 | $67.3M | $67.5M | $34.8M | $24.3M | — | View 990 |
| 2014 | $63.2M | $61.2M | $32.0M | $21.1M | — | View 990 |
| 2013 | $54.4M | $53.3M | $26.2M | $17.1M | — | View 990 |
| 2012 | $51.6M | $51.4M | $23.6M | $17.2M | — | View 990 |
| 2011 | $50.9M | $49.6M | $23.0M | $16.8M | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $81.8M, expenses of $86.5M, and assets of $54.0M (revenue +0.3% year-over-year).
- 2022: Revenue of $81.5M, expenses of $82.6M, and assets of $57.4M (revenue +4.4% year-over-year).
- 2021: Revenue of $78.0M, expenses of $78.3M, and assets of $57.7M (revenue +2.4% year-over-year).
- 2020: Revenue of $76.2M, expenses of $75.7M, and assets of $55.6M (revenue +3.1% year-over-year).
- 2019: Revenue of $73.9M, expenses of $75.7M, and assets of $45.3M (revenue +0.1% year-over-year).
- 2018: Revenue of $73.9M, expenses of $73.6M, and assets of $46.6M (revenue -2.6% year-over-year).
- 2017: Revenue of $75.8M, expenses of $75.7M, and assets of $46.8M (revenue +7.2% year-over-year).
- 2016: Revenue of $70.8M, expenses of $70.9M, and assets of $40.3M (revenue +5.1% year-over-year).
- 2015: Revenue of $67.3M, expenses of $67.5M, and assets of $34.8M (revenue +6.5% year-over-year).
- 2014: Revenue of $63.2M, expenses of $61.2M, and assets of $32.0M (revenue +16.2% year-over-year).
- 2013: Revenue of $54.4M, expenses of $53.3M, and assets of $26.2M (revenue +5.5% year-over-year).
- 2012: Revenue of $51.6M, expenses of $51.4M, and assets of $23.6M (revenue +1.3% year-over-year).
- 2011: Revenue of $50.9M, expenses of $49.6M, and assets of $23.0M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Crohns & Colitis Foundation Inc:
Data Sources and Methodology
This transparency report for Crohns & Colitis Foundation Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.